health
A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research
Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London about Re-engineering pharmaceutical research. Could you speculate what you think are the biggest causes of drug failure? Aroon Hingorani: It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...
A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research
Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC) about Re-engineering pharmaceutical research. Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? Denis Lacombe: We are a non-governmental, not-for-profit organisation established for 60 years, focusing on survival and ...
A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research
Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science, about Re-engineering pharmaceutical research. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? Síle Lane: When results from clinical trials aren’t published it means the same research can get repeated unnecessarily. This ...
EU Project : PhilHumans
PhilHumans : The goal of the PhilHumans (Personal Health Interfaces Leveraging Human-MAchine Natural interactionS) project is to train a next generation of young researchers in innovative Artificial Intelligence (AI) and establish user interaction with their personal health devices in an advanced and intuitive way. PhilHumans will investigate cutting-edge AI methods for human-machine interaction in the ...
EU Project : CLARIFY
CLARIFY : There were 17 million new cases of cancer diagnosed worldwide in 2018. Survival rates of cancer patients were rather poor until recent decades, when diagnostic techniques have been improved and novel therapeutic options have been developed. It is estimated that more than 50% of adult patients diagnosed with cancer live at least 5 ...
A scientist’s opinion : Interview with Renate Heinisch about new technologies in medicine
Interview with Renate Heinisch, pharmacist, former vice-chair of Science and Technology Options Assessment (STOA) panel and now member of the European Economic and Social Committee New technologies are going to deeply affect healthcare. Will citizens be ready? Renate Heinisch: We must consider that scientific and technological innovations accompanied all of human history, since ancient times. ...
A scientist’s opinion : Interview with Professor Michel Goldman about new technologies in medicine
Interview with Michel Goldman, founder of the Institute for Interdisciplinary Innovation in Healthcare (I3H) and former Executive Director of the Innovative Medicines Initiative (IMI). How was the idea of I3H born? Michel Goldman: At the Innovative Medicines Initiative (IMI) the main goal was to bring together pharmaceutical industry and universities, patient organizations, and regulators, to ...
EU Project : MAMMO1
MAMMO1 : Breast cancer is one of the main causes of death among women worldwide. Early diagnosis by mammography scanning is the best way to prevent mortality, but it requires the intervention of a highly trained workforce (radiologists). While the demand for radiologists is on the rise, the supply is quickly diminishing worldwide. This leads ...